Table 1. Summary of literature review of erythema nodosum following various COVID-19 Vaccine.
| No. | Country | Age | Interval Period | Location of Rash | Type of Vaccine | Vaccine dose | Reference |
|---|---|---|---|---|---|---|---|
| 1 | Taiwan | 27 | 3 days | Bilateral LL | Medigen | 1st dose | (8) |
| 2 | Saudi Arabia | 22 | 1 day | Bilateral LL | Pfizer | 1st dose | (9) |
| 3 | Morocco | 66 | 2 days | All 4 limbs | Astrazeneca | 2nd dose | (10) |
| 4 | Italy | 64 | 2 days | Bilateral LL | ChAdOx1-S nCoV-19 | 1st dose | (11) |